Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Afeyan Noubar
Relationship:   Director, 10% Owner
City:   Lexington
State:   MA
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   8,070,025    

Indirect Shares

  111,880,829      
Direct Value   $20,069,860    

Indirect Value

  $80,818,933      
Total Shares   119,950,854      
Total Value   $100,888,793      


Color Kinetics Inc
 $0 Receptos, Inc.
 $0 Editas Medicine, Inc.
 $20,059,135 Seres Therapeutics, Inc.
 $10,724 Moderna, Inc.
 $0 Color Kinetics Inc
 $0 Receptos, Inc.
 $0 Editas Medicine, Inc.
 $20,059,135 Seres Therapeutics, Inc.
 $10,724 Moderna, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    10   
    0    

     Stock price went up :

    3   
    0    
     Stock price went down :
    7   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -22.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Color Kinetics Inc CLRK Director 2005-10-03 83,062 2005-10-03 12,000    Premium*  
            Agenus Inc AGEN Director 2006-12-14 0 2006-12-14 0    Premium*  
            Helicos Biosciences Corp HLCSQ Director, 10% Owner 2009-09-18 0 2009-09-18 12,192,640    Premium*  
            Receptos, Inc. RCPT 10% Owner 2013-11-18 1,693,551 0    Premium*  
            DNIB Upwind Inc BIND Director, 10% Owner 2013-09-25 0 2013-09-25 1,562,616    Premium*  
            Bg Medicine, Inc. BGMD Director, 10% Owner 2015-12-09 0 2015-12-09 1,286,274    Premium*  
            Editas Medicine, Inc. EDIT 10% Owner 2016-02-08 3,964,256 2016-02-08 991,060    Premium*  
            Selecta Biosciences Inc SELB 10% Owner 2016-06-27 0 2016-06-27 1,651,862    Premium*  
            Kaleido Biosciences, Inc. KLDO 10% Owner 0 2021-02-08 14,907,627    Premium*  
            Transmedics Group, Inc. TMDX 10% Owner 0 2019-10-29 120,595    Premium*  
            Seres Therapeutics, Inc. MCRB 10% Owner 2019-06-18 15,141 2022-07-05 17,617,352    Premium*  
            Moderna, Inc. MRNA 2024-06-12 2,314,015 2024-06-12 4,632,149    Premium*  
            Axcella Health Inc. AXLA 10% Owner 2020-05-18 0 2022-10-13 8,850,296    Premium*  
            Evelo Biosciences Inc EVLO 2020-06-29 0 2023-07-11 4,977,588    Premium*  
            Codiak Biosciences, Inc. CDAK 10% Owner 0 2022-09-15 1,674,869    Premium*  
            Foghorn Therapeutics Inc. FHTX 10% Owner 2020-10-27 0 2020-10-27 1,851,801    Premium*  
            Sigilon Therapeutics, Inc. SGTX 10% Owner 2020-12-08 0 2023-08-11 0    Premium*  
            Sana Biotechnology, Inc. SANA 10% Owner 2021-02-08 0 2023-09-13 581,695    Premium*  
            Rubius Therapeutics, Inc. RUBY Director, 10% Owner 2021-03-19 0 2021-03-19 17,253,519    Premium*  
            Omega Therapeutics, Inc. OMGA Director, 10% Owner 2021-08-03 0 2023-02-27 21,716,886    Premium*  
* Premium Members only  

Records found :    149         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
AGEN Agenus Inc Director   –       •      –    2006-12-14 4 S $1.95 $9,759 D/D (5,000) 0 0 -
CLRK Color Kinetics Inc Director   –       •      –    2007-08-24 4 D $34.00 $2,810,338 D/D (82,657) 0 0 -
BGMD Bg Medicine, Inc. Director   –       •       •   2015-12-09 4 S $0.56 $1,404 I/I (2,508) 0 0 -
BGMD Bg Medicine, Inc. Director   –       •       •   2015-12-09 4 S $0.56 $24,601 D/D (43,930) 0 0 -
TMDX Transmedics Group, Inc. 10% Owner   –       –       •   2019-05-06 4 D $0.00 $0 I/I (1,690,579) 0 0 -
TMDX Transmedics Group, Inc. 10% Owner   –       –       •   2019-10-29 4 D $0.00 $0 I/I (2,840,191) 0 0 -
MRNA Moderna, Inc. Director   –       •       •   2020-05-11 4 D $0.00 $0 I/I (12,281,179) 0 0 -
MRNA Moderna, Inc. Director   –       •       •   2020-08-17 4 D $0.00 $0 I/I (11,053,049) 0 0 -
MCRB Seres Therapeutics, Inc. 10% Owner   –       –       •   2020-11-23 4 D $0.00 $0 I/I (7,907,179) 0 0 -
SGTX Sigilon Therapeutics, Inc... 10% Owner   –       –       •   2023-08-11 4 D $14.92 $11,901,982 I/I (797,720) 0 0 -
SANA Sana Biotechnology, Inc. 10% Owner   –       –       •   2023-09-13 4 D $0.00 $0 I/I (11,781,275) 0 0 -
CLRK Color Kinetics Inc Director   –       •      –    2004-12-08 4 GA $0.00 $0 I/I 12,000 12,000 -
CLRK Color Kinetics Inc Director   –       •      –    2004-06-25 4 A $0.00 $0 D/D 93,237 13,318 -
CLRK Color Kinetics Inc Director   –       •      –    2004-12-08 4 GD $0.00 $0 D/D 12,000 81,237 -
CLRK Color Kinetics Inc Director   –       •      –    2005-04-01 4 A $10.19 $6,491 D/D 637 81,874 -
CLRK Color Kinetics Inc Director   –       •      –    2005-07-01 4 A $11.00 $6,490 D/D 590 82,464 -
CLRK Color Kinetics Inc Director   –       •      –    2006-11-15 4 S $17.96 $3,447,360 D/D (192,000) 82,657 0 -
CLRK Color Kinetics Inc Director   –       •      –    2006-12-13 4 S $17.96 $1,258,197 D/D (70,075) 82,657 0 -
CLRK Color Kinetics Inc Director   –       •      –    2005-10-03 4 A $15.05 $9,000 D/D 598 83,062 0 -
RCPT Receptos, Inc. 10% Owner   –       –       •   2013-05-08 3 IO $0.00 $0 D/D 0 114,285 -
CLRK Color Kinetics Inc Director   –       •      –    2006-12-13 4 OE $2.98 $208,824 D/D 70,075 152,732 0 -
TMDX Transmedics Group, Inc. 10% Owner   –       –       •   2019-05-06 4 A $0.00 $0 I/I 483,021 268,736 0 -
CLRK Color Kinetics Inc Director   –       •      –    2006-11-15 4 OE $2.38 $455,996 D/D 191,595 274,657 0 -
TMDX Transmedics Group, Inc. 10% Owner   –       –       •   2019-05-01 3 IO $0.00 $0 I/I 0 483,021 -
CDAK Codiak Biosciences, Inc. 10% Owner   –       –       •   2020-10-13 3 IO $0.00 $0 I/I 0 485,949 -

  149  Records found
  1  2   3   4   5   6      
  Page 1 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed